Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
Athena Philis‐Tsimikas, Marisse Asong, Edward Franek, Ting Jia, Julio Rosenstock, Karolina Stachlewska, Hirotaka Watada, Monika Kellerer
Topics & Concepts
Insulin degludecMedicineInsulinType 2 diabetesAdverse effectDiabetes mellitusInternal medicineRandomized controlled trialBasal insulinEndocrinologyDiabetes Management and ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins